Agios Pharmaceuticals | AGIO - Gross Profit On Sales


Agios Pharmaceuticals reported $18.09M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Agios Pharmaceuticals USD 18.09M 6.89M Dec/2025
Alnylam Pharmaceuticals USD 829.31M 219.56M Dec/2025
Amgen USD 6.48B 307M Sep/2025
Arrowhead Research USD 256.47M 228.7M Sep/2025
Astellas Pharma JPY 444.26B 12.55B Mar/2026
AstraZeneca USD 12.39B 5M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
BioMarin Pharmaceutical USD 713.01M 81.81M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Exelixis USD 572.18M 7M Dec/2025
Gilead Sciences USD 6.31B 106M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Incyte USD 1.17B 217.51M Mar/2026
Ionis Pharmaceuticals USD 195M 40M Dec/2025
Merck USD 13.42B 431M Sep/2025
Moderna USD 226M 583M Dec/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Novartis USD 10.25B 570M Dec/2025
Novartis USD 10.82B 694M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Regeneron Pharmaceuticals USD 3.3B 67M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 43.55M 204.36M Dec/2025
Vertex Pharmaceuticals USD 2.72B 62.4M Dec/2025